Hire an Advanced Robo-Advisor to Trade CELG on Your Behalf.

Stock Detail Header
  • Street Sentiment
  • Personalized Strategy
  • Free Trading Simulator
Get Started
Stock Details
  • PRICE$105.18
  • PRICE CHANGE$0.68
  • % CHANGE0.65%
  • TWEETS56
  • CONSENSUSHOLD

Trends

Course of Action

HOLD

Sentiment (10 days)

  •  Strong Buy
  •  Buy
  •  Hold
  •  Sell
  •  Strong Sell

DAILY PRICE CHANGE VS SENTIMENT

  • BullishBullish
  • BearishBearish
  • SentimentSentiment
  • BarPrice

Why Use a Robo-Advisor to invest?

Smart Auto-Trading is an advanced robo-advisor designed to provides investors with a trading partner to automate systematic investing. Its robo is designed to screens, monitors and auto-trades elite stocks like CELGENE CORPORATION (CELG) using artificial intelligence, social media and market data to augments your potential as an investor.

Smart Auto-Trading produces short-term trades which makes it an ideal tool for trading in tax-deferred accounts such as IRA, SIMPLE IRA, Rollover IRA, 529 College Plans, Keoghs and UGMA. It also works in taxable accounts. Just be aware that if you elect to auto-trade using Smart Auto-Trading in a regular brokerage account, you will be taxed at regular income. Make sure you understand your tax situation before using Smart Auto-trading.

Using Smart Auto-Trading is easy. It connects to your brokerage account at Ally Invest, one of the most trusted broker/dealer in the United States. All you need to do is open an account with them, put a minimum of $5,000 in your account and connect Smart Auto-Trading to trade.

Benefits

There are clear benefits associated with using a robo-advisor such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.

'Trading on the news' is a technique used by traders to justify buying or selling securities. News reports often spur short-term moves in the market, creating trading opportunities.

Announcements about earnings, product launches, changes in management, all are events that can cause a company's stock price to move up or down.

Digital news sources

Today, news travels through digital means. It reaches social networks at breakneck speed. News can spread virally from the originator to millions of people in a matter of minutes. If the news has material value, it is re-tweeted immediately.

News sentiment analysis

Smart Auto-Trading sift through 1000s of news elements in seconds, figure out the subject, how many people are talking about it and if the news is positive or negative.

With this technology, gone are the days of staring at a Bloomberg terminal for the purpose of identifying trading opportunities. Computers essentially have mastered how to 'trade on the news'. This technology is virtually eliminating the need to pay someone to watch over your portfolio.

Sentiment based Wall Street

As of 2009, Wikipedia states that computers who are using events to trigger trades, accounted for 60% of all US stock market trading volume.' In 2017, this phenomenon has ballooned to 75% of all equity trades.

Wall Street's automated strategies have become so pervasive that we can say that the market is about to become fully robotized.

Automated 'trading on the news' brings about a new world of opportunities, where investors will get a better 'bang for their buck' without the need for a traditional Investment Advisor. All they will really need is a brokerage account and access to their favorite auto-trading tool.

Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.

Smart Auto-Trading actively trades which is different from passive investing. The robo is on the lookout working to maximize your potential every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.

Smart Auto-Trading is one of the first robo-advisor to take advantage of Government grade listening technology, artificial intelligence, social media and market data natively.

Try Smart Auto-Trading today!

You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.

Get started now - and see where active automated trading can take you.

Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Advisors like other investment methods rely on favorable market conditions to provide positive outcomes.

CELGENE CORPORATION (CELG) News

Celgene plunges 18% after biotech company slashes 2020 guidance; worst drop in 17 years

Investors are panicking over Celgene's new long term sales guidance.

The shares of the biotech company opened down 18 percent Thursday after it reduced 2020 sales guidance to range of $19 billion to $20 billion from its previous forecast of more than $21 billion. Celgene also lowered its 2020 earnings-per-share guidance to more than $12.50 from more than $13.00. The percentage drop in the shares is the largest in 17 years.

"In consideration of certain market dynamics and recent pipeline events, we are updating our 2020 outlook, and remain confident in our ability to deliver industry leading growth," Celgene CEO Mark Alles said in a company press release Thursday.

"Over the coming months, we look forward to sharing data supporting our innovative, next generation pipeline products and significant growth drivers."

The company's new long term guidance outweighed its better than expected third-quarter earnings results.

"Celgene just reported 3Q17 results. Quarter doesn't matter here (Revlimid ok, decent miss on Otezla, total revenue missed on Otezla, but EPS beat by 3 pennies from cost control)," Mizuho analyst Salim Syed wrote in a note to clients Thursday. "The most important thing in the press release is that CELG has now taken down its 2020 guidance."

It has been a difficult month for the biotech company. Celgene announced on Oct. 19 it would not initiate a phase 3 trial for a Crohn's disease drug, spurring a 11 percent share drop the next day.

Celgene shares have rallied 3 percent year-to-date through Wednesday compared to the S&P 500's 14 percent gain.

Get Started today! - Risk Free

Investors who like CELGENE CORPORATION (CELG) also like

Most Talked About Stocks on Stock Circles

Stock Bubbles